Skip to search formSkip to main contentSkip to account menu
  • Publications
  • Influence
Randomized, placebo-controlled trial of exposure and ritual prevention, clomipramine, and their combination in the treatment of obsessive-compulsive disorder.
TLDR
Intensive exposure and ritual prevention may be superior to clomipramine and, by implication, to monotherapy with the other SRIs and their combination are all efficacious treatments for OCD.
View on PubMed
Practice guideline for the treatment of patients with obsessive-compulsive disorder.
TLDR
The guideline remains substantially correct and current in its recommendations, and some recommendations are now supported by stronger evidence, and more data is available regarding rates of response to some interventions.
View on PubMed
The OCI-R: validation of the subscales in a clinical sample.
View on PubMed
Randomized sham-controlled trial of repetitive transcranial magnetic stimulation in treatment-resistant obsessive-compulsive disorder.
TLDR
The results of the first randomized sham-controlled trial of SMA stimulation in the treatment of resistant OCD support further investigation into the potential therapeutic applications of rTMS in this disabling condition.
View on PubMed
Obsessive–compulsive disorder: a review of the diagnostic criteria and possible subtypes and dimensional specifiers for DSM‐V
TLDR
A number of changes to the existing diagnostic criteria for OCD are proposed, and these proposed criteria may change as the DSM‐V process progresses.
View on Wiley
Repeated Cortico-Striatal Stimulation Generates Persistent OCD-Like Behavior
What Causes Obsessive Compulsive Disorder? Obsessive compulsive disorder is a severe, chronic mental illness that affects millions of individuals. However, the mechanisms underlying this disease are…
View on Publisher
Cognitive-behavioral therapy vs risperidone for augmenting serotonin reuptake inhibitors in obsessive-compulsive disorder: a randomized clinical trial.
TLDR
Adding EX/RP to SRIs was superior to both risperidone and pill placebo in improving insight, functioning, and quality of life in adults with OCD.
View on PubMed
A randomized, controlled trial of cognitive-behavioral therapy for augmenting pharmacotherapy in obsessive-compulsive disorder.
TLDR
Augmentation of SRI pharmacotherapy with exposure and ritual prevention is an effective strategy for reducing OCD symptoms, however, 17 sessions were not sufficient to help most of these patients achieve minimal symptoms.
View on PubMed
Rationale for the application of exposure and response prevention to the treatment of anorexia nervosa.
TLDR
A model of AN is suggested in which baseline anxiety features yield eating related fears, avoidance behaviors, and ritualized safety behaviors that promote the underweight state and the perpetuation of the disorder.
View on PubMed
Prevalence and correlates of fire-setting in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC).
TLDR
The findings suggest that fire-setting may be better understood as a behavioral manifestation of a broader impaired control syndrome and part of the externalizing spectrum.
View on PubMed
...
...
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License